metformin or glp 1 Metformin: Anchoring Potential in GLP-1 RA Care Journey Emerging research suggests that GLP-1

After 2 hours, islets were subjected to either liraglutide (100 nM) (107, 108) or saline treatment for 12 hours (DART-Seq) (8, 85, 109) in order to assess changes in RNA expression or 24 hours (7, 85, 107) (IHC, active GLP-1 measurements) in order to assess changes in protein content, as previously validated (85)

however, treatment with liraglutide was able to rescue some of this impairment, indicating that GLP-1R agonism may help restore learning capacity (Hanssen et al., 2023)

[DOI] [PubMed] [Google Scholar] 44.Meyer EJ, Wittert GA

Effect of 6week course of glucagonlike peptide 1 on glycaemic control, insulin sensitivity, and betacell function in type 2 diabetes: A parallelgroup study

Non-GLP-1 medications often produce modest weight losses of 5-10%, making them secondary options when GLP-1 therapy is contraindicated or poorly tolerated